The groundbreaking approach of tirzepatide peptide represents a exciting breakthrough in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – resulting in enhanced blood sugar regulation and anticipated reduction in weight. Researchers are studying its long-term benefits and part in the broa